Adenovirus-Associated Thrombocytopenia, Thrombosis, and VITT-like Antibodies  New England Journal of Medicine. 2023;389(6):574-577
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37590457

Association between high galectin expression and poor prognosis in hematologic cancers: a systematic review and meta-analysis  Hematology (Amsterdam, Netherlands). 2023;28(1):2227494
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37343172

Attrition and withdrawal in multiple myeloma randomized controlled trials: A systematic review  European Journal of Haematology. 2023;111(3):491-498
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37382045

A Case of Fetal-Induced Graft-versus-Host Disease  New England Journal of Medicine. 2023;389(7):668-670
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37585636

Cold Agglutinin Syndrome  New England Journal of Medicine. 2023;389(7):642
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37585630

CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease  New England Journal of Medicine. 2023;389(9):820-832
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37646679

Eculizumab was safe and effective in the management of transplant-associated thrombotic microangiopathy in a heart transplant recipient with concurrent COVID-19 infection  Internal Medicine Journal. 2023;53(8):1506-1508
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37599228

Effect modification in network meta-analyses for relapsed/refractory multiple myeloma: systematic review and meta-analysis  BMJ Open. 2023;13(8):e067966
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37643851

Effectiveness of aortic valve replacement in Heyde syndrome: a meta-analysis  European Heart Journal. 2023;44(33):3168-3177
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37555393

The efficacy and safety of venetoclax and azacytidine combination treatment in patients with acute myeloid leukemia and myelodysplastic syndrome: systematic review and meta-analysis  Hematology (Amsterdam, Netherlands). 2023;28(1):2198098
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37036307

Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in patients with hip fracture (the HiFIT trial): a multicentre, 2 × 2 factorial, randomised, double-blind, controlled trial  Lancet Haematol. 2023;10(9):e747-e755
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37524101

Iron supplements in pregnant women with normal iron status: A systematic review and meta-analysis  Acta Obstetricia et Gynecologica Scandinavica. 2023;102(9):1147-1158
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37403900

Management of Acquired Factor X Deficiency Caused by In Vitro Non-neutralizing Anti-factor X Autoantibodies with Pre-emptive Corticosteroid Therapy  Internal Medicine. 2023;62(16):2401-2406
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37587057

Management of Primary Immune Thrombocytopenia in Pregnancy  New England Journal of Medicine. 2023;389(6):540-548
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37590449

Outcome following laser surgery of twin-twin transfusion syndrome complicated by selective fetal growth restriction: systematic review and meta-analysis  Ultrasound in Obstetrics and Gynecology. 2023;62(3):320-327
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37204823

Outcome of an elective readmission policy in patients receiving acute myeloid leukaemia consolidation therapy and implications for an outpatient management programme  Internal Medicine Journal. 2023;53(8):1492-1496
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37599226

Phase 3 Trial of Concizumab in Hemophilia with Inhibitors  New England Journal of Medicine. 2023;389(9):783-794
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37646676

PSTPIP1-Associated Myeloid-Related Proteinemia Inflammatory (PAMI) Syndrome: A Systematic Review  Genes (Basel). 2023;14(8)
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37628706

Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics study  Platelets. 2023;34(1):2157806
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36597010

Renal Artery Thrombosis in Essential Thrombocythemia  New England Journal of Medicine. 2023;389(9):e16
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37646681

Scedosporium species and Lomentospora prolificans fungaemia is uniformly fatal in patients with haematological malignancy  Internal Medicine Journal. 2023;53(8):1489-1491
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37599232

Sickle cell disease and coronavirus disease-2019 (COVID-19) infection: a single-center experience  Postgraduate Medical Journal. 2023;99(1175):1008-1012
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37399057

Spinal Cord Infarction in an Adolescent with Protein S Deficiency: A Case Report and Literature Review  Internal Medicine. 2023;62(16):2415-2418
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36631088

A systematic review comparing allogeneic hematopoietic stem cell transplant to gene therapy in sickle cell disease  Hematology (Amsterdam, Netherlands). 2023;28(1):2163357
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36728286

Systemic Inflammation and Normocytic Anemia in DOCK11 Deficiency  New England Journal of Medicine. 2023;389(6):527-539
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37342957